Physician profile
Hassan Dbouk
NPI 1790807675
$1,484.18
in general payments reported to CMS, 2019-2025
17 companies · $62.72 in 2025
The $62.72 reported for 2025 was less than what a typical Sleep Medicine (Pediatrics) provider received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $102 · 2021: $106 · 2022: $281 · 2023: $46.32 · 2024: $76.11 · 2025: $62.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $340.84 | 2019-2025 | Creon |
| Janssen Pharmaceuticals, INC | $164.70 | 2019 | |
| Boston Scientific Corporation | $149.50 | 2022 | |
| Allergan, INC. | $145.31 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $139.40 | 2019-2024 | |
| Pfizer INC. | $133.24 | 2019 | |
| Chiesi USA, INC. | $105.27 | 2019-2022 | |
| Novo Nordisk INC | $77.68 | 2019 | |
| Phadia US INC. | $75.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $31.35 | 2019 | |
| Advanced Respiratory, INC | $26.44 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $24.69 | 2024 | Dupixent |
| Amgen INC. | $19.33 | 2022 | |
| Inspire Medical Systems, INC. | $13.70 | 2023 | Inspire |
| Gilead Sciences, INC. | $13.23 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $12.97 | 2019 | |
| Mylan Specialty L.P. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Dbouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.